Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
TransDigm Second Quarter Earnings Report and Conference Call Set for Tuesday, May 6, 2025
-
enGene to Participate in Upcoming Investor Conferences
-
DTN Launches First Hurricane Forecasting Tool That Captures Full Range of Threats
-
New Research Finds Building with Zinc Prevents Substantial Carbon Emissions
-
Alnylam Receives Positive CHMP Opinion for Vutrisiran for the Treatment of ATTR Amyloidosis with Cardiomyopathy
-
Dollar Tree Announces Chief Supply Chain Officer Transition
-
New RADX PXIe-GPUs Deliver Up To 30.3 FP32 TFLOPS for T&M Applications
-
IN8bio Unveils Promising New Data from Next Generation Gamma-Delta T Cell Engager (TCE) Platform at AACR 2025
-
Sensydia Announces First Patient Enrolled in Pivotal Study of Non-Invasive Cardiac Performance System (CPS™)
-
The Club Français des Brunos et des Chiens Courants Suisses organizes its Nationale d'Élevage 2025 at Mende
-
SS&C Announces 2025 SS&C Deliver EMEA Conference
-
Smartlinx Acquires Software Provider StafferLink to Streamline Workforce Operations in Healthcare
-
Media Advisory: Surescripts Experts to Present Innovative Interoperability & Prior Authorization Technologies at 2025 NCPDP Annual Conference May 5-7
-
Schrödinger Presents New Preclinical Data at AACR Annual Meeting
-
Appknox Launches Storeknox, Revolutionizes Mobile App Security with Continuous Store Monitoring
-
BigCommerce and Silk Commerce Launch Distributed Ecommerce Hub to Power Scalable Storefront Networks for Dealers, Distributors and Franchises
-
Financial Services Firms Deepen Client Engagement with ON24-powered Digital Experiences
-
Nocion Therapeutics Appoints Matthew Frankel, M.D., MBA to Chief Medical Officer
-
Arch Amenities Group Appoints Operations, HR and IT Executives
-
Space Flight Laboratory (SFL) Announces Key Milestone in Development of Aspera Space Astronomy Microsatellite Mission
-
Zentalis Pharmaceuticals Announces First Patient Dosed in DENALI Part 2 Clinical Trial of Azenosertib in Patients with Cyclin E1+ PROC
-
JLens and ADL Urge Meta Shareholders to Vote FOR Shareholder Proposal Addressing the Risks of Online Antisemitism and Other Forms of Hate
-
School District Leaders Join Forces to Increase Scratch Cooking for Healthier Student Meals
-
Operation HOPE and Financial Literacy for All’s Green Socks Day Takes Place This Week on April 30
-
Actinium Highlights Mutation Agnostic Antileukemic Activity of Actimab-A Against FLT3, NPM1, KMT2A and TP53 Mutations in AML Models Demonstrating Backbone Potential for Acute Myeloid Leukemia Treatmen
-
Easterly Government Properties Completes Reverse Stock Split
-
New Cloud Security Alliance Certification Program Equips Professionals With Skills to Ensure Responsible and Safe Development and Management of Artificial Intelligence (AI)
-
Bitget Drops Exclusive LALIGA Skins: Trade in Style with Barça, Real Madrid & More
-
New Research from LevelBlue Indicates How AI is Challenging Organizations to Rethink Cyber Resilience
-
24 Hour Fitness Unveils New Amenity Concepts Designed to Redefine the Member Experience
-
Pluri Completes Strategic Acquisition of Leading Cultivated Cacao AgFoodTech Company, Kokomodo Ltd.
-
MMA.inc Partners with Brazilian Jiu-Jitsu Icon Clark Gracie: Accelerates BJJLink Expansion and Unlocks Potential New Revenue Streams Across Over 5,700 New Students
-
LayerX Security Extends Series A Funding to $37M to Power Next-Gen Enterprise Browser Security, Challenges SSE Solutions and Enterprise Browsers
-
MicroAlgo Announces Strong Net Income and Cash Growth in 2024, Driven by Robust Demand for Central Processing Algorithm Services
-
CareCloud Launches Healthcare AI Center Set to Become World’s Largest with 500 AI Professionals
-
Qdrant Receives Industry Honors for Innovation in AI and Vector Search
-
Sunrun Installs Solar Projects at Three Affordable Apartment Communities in Southern California, Providing Energy Bill Savings to 800 Renters
-
Chemomab Reports New Positive Clinical Data at EASL 2025 Supporting Nebokitug’s Impact in Primary Sclerosing Cholangitis and Related Diseases
-
Impulse Dynamics®’ INTEGRA-D Trial Completes Efficacy Phase
-
Adagene Appoints John Maraganore, Ph.D. as Executive Advisor
-
Northstrive Biosciences Co-Founder Featured on Bear Bull Traders Following Announcement of Positive FDA Response Supporting Submission of IND for EL-22 Phase 2 Clinical Trial
-
Concentrix Launches CyberProtect Managed Service Offering
-
Volaris Reports Financial Results for the First Quarter 2025
-
Foremost Clean Energy Announces National Marketing Campaign
-
Calidi Biotherapeutics Announces IL15 Superagonist as First Payload to be Delivered by Systemic Antitumor Virotherapy Platform at AACR Annual Meeting
-
PetPace™ Wins Global Tech Award for Wearable Technology, Marking Third Major Industry Honor
-
Montai Therapeutics Appoints Allison Bogosian, JD, as Chief People and Administrative Officer
-
Bright Minds Biosciences to Host Virtual R&D Day on May 20, 2025; Program Highlights Include an Overview of Absence Seizures and the BMB-101 Phase 2 Study
-
Kratos Defense & Security Solutions Schedules First Quarter 2025 Earnings Conference Call for Wednesday, May 7th
-
Redwood to Highlight Logistics Digitalization at Gartner Supply Chain Symposium 2025

